244 related articles for article (PubMed ID: 18567838)
1. Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.
Arendt BK; Ramirez-Alvarado M; Sikkink LA; Keats JJ; Ahmann GJ; Dispenzieri A; Fonseca R; Ketterling RP; Knudson RA; Mulvihill EM; Tschumper RC; Wu X; Zeldenrust SR; Jelinek DF
Blood; 2008 Sep; 112(5):1931-41. PubMed ID: 18567838
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific (localized) synthesis of Ig light chain amyloid.
Hamidi Asl K; Liepnieks JJ; Nakamura M; Benson MD
J Immunol; 1999 May; 162(9):5556-60. PubMed ID: 10228037
[TBL] [Abstract][Full Text] [Related]
3. Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.
Perfetti V; Casarini S; Palladini G; Vignarelli MC; Klersy C; Diegoli M; Ascari E; Merlini G
Blood; 2002 Aug; 100(3):948-53. PubMed ID: 12130507
[TBL] [Abstract][Full Text] [Related]
4. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
[TBL] [Abstract][Full Text] [Related]
5. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
Elife; 2020 Mar; 9():. PubMed ID: 32151314
[TBL] [Abstract][Full Text] [Related]
6. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
[TBL] [Abstract][Full Text] [Related]
7. The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo models.
Ohno S; Yoshimoto M; Honda S; Miyachi S; Ishida T; Itoh F; Endo T; Chiba S; Imai K
J Immunol; 2002 Oct; 169(7):4039-45. PubMed ID: 12244207
[TBL] [Abstract][Full Text] [Related]
8. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.
Comenzo RL; Zhang Y; Martinez C; Osman K; Herrera GA
Blood; 2001 Aug; 98(3):714-20. PubMed ID: 11468171
[TBL] [Abstract][Full Text] [Related]
9. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
[TBL] [Abstract][Full Text] [Related]
10. Local synthesis of amyloid fibril precursor in AL amyloidosis of the urinary tract.
Hamidi Asl K; Liepnieks JJ; Bihrle R; Benson MD
Amyloid; 1998 Mar; 5(1):49-54. PubMed ID: 9547006
[TBL] [Abstract][Full Text] [Related]
11. Amyloidogenic light chains impair plasma cell survival.
Pick M; Lebel E; Elgavish S; Benyamini H; Nevo Y; Hertz R; Bar-Tana J; Rognoni P; Merlini G; Gatt ME
Haematologica; 2023 Dec; 108(12):3359-3371. PubMed ID: 37381778
[TBL] [Abstract][Full Text] [Related]
12. Inducing the loss of immunoglobulin lambda light chain production and the rearrangement of a previously excluded allele in human plasma B cell lines with concanavalin A.
Tachibana H; Ushio Y; Krungkasem C; Shirahata S
J Biol Chem; 1996 Jul; 271(29):17404-10. PubMed ID: 8663345
[TBL] [Abstract][Full Text] [Related]
13. Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.
Miyazaki K; Suzuki K
Amyloid; 2016 Dec; 23(4):221-224. PubMed ID: 27682970
[TBL] [Abstract][Full Text] [Related]
14. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
Olsen KE; Sandgren O; Sletten K; Westermark P
Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
[TBL] [Abstract][Full Text] [Related]
15. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.
Stevens PW; Raffen R; Hanson DK; Deng YL; Berrios-Hammond M; Westholm FA; Murphy C; Eulitz M; Wetzel R; Solomon A
Protein Sci; 1995 Mar; 4(3):421-32. PubMed ID: 7795526
[TBL] [Abstract][Full Text] [Related]
16. The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44.
Perfetti V; Palladini G; Casarini S; Navazza V; Rognoni P; Obici L; Invernizzi R; Perlini S; Klersy C; Merlini G
Blood; 2012 Jan; 119(1):144-50. PubMed ID: 22067386
[TBL] [Abstract][Full Text] [Related]
17. A strategy for synthesis of pathogenic human immunoglobulin free light chains in E. coli.
Rognoni P; Lavatelli F; Casarini S; Palladini G; Verga L; Pedrazzoli P; Valentini G; Merlini G; Perfetti V
PLoS One; 2013; 8(9):e76022. PubMed ID: 24086679
[TBL] [Abstract][Full Text] [Related]
18. Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).
Abraham RS; Geyer SM; Ramírez-Alvarado M; Price-Troska TL; Gertz MA; Fonseca R
J Clin Immunol; 2004 Jul; 24(4):340-53. PubMed ID: 15163890
[TBL] [Abstract][Full Text] [Related]
19. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
20. Light chain amyloidosis - current findings and future prospects.
Baden EM; Sikkink LA; Ramirez-Alvarado M
Curr Protein Pept Sci; 2009 Oct; 10(5):500-508. PubMed ID: 19538145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
